Skip to content

Evaluation of blood counts (platelet values) done routinely in pregnant women with high BP recordings and assessing the severity by comparing with the normal pregnant women .

Significant role of platelet indices in predicting the severity of pre-eclampsia

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2017/11/010606
Enrollment
88
Registered
2017-11-23
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: null- Pregnant women with pre-eclampsia as cases and healthy pregnant women as controls.

Interventions

None listed

Sponsors

Dr Shifali RL
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Cases:- Pregnant woman more than 20 weeks of gestation who are booked cases in KH, manipal with BP > 140/90mmhg on two measurements taken 6 hours apart, with Proteinuria of more than 300 mg in 24 hours urine were included in the pre-eclampsia group. Control :- Healthy pregnant women with similar demographic age will be included in the study as a control group.

Exclusion criteria

Exclusion criteria: Multiple pregnancy Morbid obesity ( BMI> 40) Intrauterine fetal death Poor past obstetric history Medical disorders (chronic hypertension, diabetes mellitus, diseases, renal diseases, hepatic dysfunction

Design outcomes

Primary

MeasureTime frame
1) To study the variation of platelet indices in pre-eclampsia patients. 2) To compare the platelet indices between the normal and pre-eclampsia patients. 3) To assess the relationship between severity of pre-eclampsia and platelet indices and whether these indices can be used as a prognostic marker.Timepoint: 1 Year

Secondary

MeasureTime frame
Pre- eclampsia continues to be the major cause of maternal and perinatal mortality. So there is a constant search for better prognostic factors to predict the progression and severity of the disease.Timepoint: 1 Year

Countries

India

Contacts

Public ContactDR SHIFALI RL

KMC HOSPITAL MANIPAL

rex2000@rediffmail.com917338086102

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026